期刊文献+

超声药物透入中药治疗恶性腹水疗效观察

Effect of ultrasonic drug penetration with traditional Chinese medicine in malignant ascites
下载PDF
导出
摘要 目的观察超声药物透入腹水1号方治疗恶性腹水的临床疗效。方法选择该科2015年8月至2016年12月合并恶性腹水的肿瘤患者60例,按随机数字表法分为治疗组(30例)和对照组(30例)。治疗组采用超声药物透入腹水1号方联合腹腔灌注顺铂化疗控制腹水,对照组采用超声药物透入生理盐水联合腹腔灌注顺铂化疗控制腹水。2周后行腹水B超判定疗效,观察2组患者腹水引流间隔时间、临床症状及疗效。结果治疗组治疗总有效率[73.33%(22/30)]明显高于对照组[56.67%(17/30)],差异有统计学意义(P<0.05)。治疗组腹水引流间隔时间较对照组明显延长,患者乏力、腹胀、纳呆、尿量减少等症状较对照组明显改善,差异均有统计学意义(P<0.05)。两组均无不良反应发生。结论超声药物透入腹水1号方治疗恶性腹水,疗效显著,不良反应小,值得进一步在临床推广应用。 Objective To observe the clinical efficacy of ultrasonic drug penetration with"Fushui-1 decoction"in malignant ascites. Methods A total of 60 patients tumor with malignant in the hospital from August 2015 to December 2016 were randomly divided into the treatment group(30 cases)and the control group(30 cases).The treatment group used ultrasonic drug penetration with"Fushui-1 decoction"and intraperitoneal infusion of cisplatin to cure ascites,the control group replaced with saline solution in ultrasonic drug penetration,other treatments were same as the treatment group.Ascites ultrasonography were used to evaluate the curative effect after two weeks.Ascites drainage interval time,clinical symptoms and effectiveness were also observed in the two groups. Results The total effective rate in the treatment group[73.33%(22/30)]was higher than that in the control group[56.67%(17/30)],the difference was statistically significant(P0.05).The ascites drainage interval time in the treatment group was significant longer than that in the control group,the symptoms of patients withfatigue,abdominal distension,anorexia and hypourocrinia were more significantly improved in the treatment group than those in the controlled group,the differences were statistically significant(P0.05). There were no adverse reactions occurred in the two groups. Conlusion Ultrasonic drug penetration with"Fushui-1 decoction"demonstrates a higher efficacy of malignant ascites,and the adverse effects are minor.It is worthy of further clinical application.
作者 赖宗浪 宋娜 刘娜 刘勇 孟令占 LAI Zonglang;SONG Na;LIU Na;LIU Yong;MENG Lingzhan(Chongqing Traditional Chinese Medicine Hospital,Chongqing 400011,China)
出处 《现代医药卫生》 2018年第12期1789-1791,共3页 Journal of Modern Medicine & Health
基金 重庆市科委项目(520101-2016394)
关键词 腹水 超声透入疗法 中草药 肿瘤 腹水1号方 Aseites Phonophoresis Drugs,Chinese herbal Neoplasms Fushui-1 decoetion
  • 相关文献

参考文献6

二级参考文献40

  • 1Ba, Ming-Chen,Cui, Shu-Zhong,Lin, Sheng-Qu,Tang, Yun-Qiang,Wu, Yin-Bing,Wang, Bin,Zhang, Xiang-Liang.Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites[J].World Journal of Gastroenterology,2010,16(15):1901-1907. 被引量:50
  • 2秦月花,傅文安,王丽敏,潘颖颖.芒硝联合施他宁治疗重症急性胰腺炎的临床研究[J].中国中西医结合急救杂志,2006,13(3):187-188. 被引量:18
  • 3田娟,王维皓,高慧敏,王智民.HPLC测定复方苦参注射液中苦参碱、槐定碱和氧化苦参碱的含量[J].中国中药杂志,2007,32(3):222-224. 被引量:61
  • 4周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2006:430-431.
  • 5.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.346-348.
  • 6Ayantunde AA, Parsons SL. Pattem and prognostic factors in patients with malignant ascites, a retrospective study. Ann of Oncol, 2007,18:945.
  • 7Becker G. Medical and palliative management of malignant ascites [ J ]. Cancer Treat Res, 2007 (134) :459 - 467.
  • 8Rosenberg SM. Palliation of malignant ascites[ J]. Gastroenterol Clin North Am, 2006, 35 (1) :189 -199.
  • 9Beeker G, Galandi D, Blum HE. Malignant ascites: systematic re- view and guideline for treatment [ J ]. Eur J Cancer, 2006,42 (5) : 589 - 597.
  • 10Xu L, Yoneda J, Herrera C, et al. Inhibition of malignant ascites and growth of human ovarian carcinoma by oraladministration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases [ J ]. Int J Oncol,2000,16 ( 3 ) : 445 - 454.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部